This Atlanta Founder Secured a $2m Seed Round With a Cold Email, Meet Gaurav Byagathvalli of Piezo

After recently securing $2M in new seed funding, Atlanta startup Piezo Therapeutics is off to the races in launching their new platform which empowers a safer and more efficient way to bring new medicines to market. Founder and Georgia Tech Alumni, Gaurav Byagathvalli, has gone all-in on his passion for biotech building, pivoting from his former role as a product manager. After five years of research and development in the Bhamla Lab at Georgia Tech, Piezo Therapeutics is poised to shake up the world of drug delivery with its innovative technology. But how did they get here? Join us as Gaurav shares his insights on the technological headwinds the industry has faced, the impact of Piezo's platform on the biotech landscape, and how a simple cold email paved the way for their seed round. Plus, stick around for Gaurav's predictions on the rapidly-evolving life sciences and the biotech scene in Atlanta. 

Let's take this conversation to real time. Join Valor for an upcoming event.